438 related articles for article (PubMed ID: 25138075)
1. A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels.
Venderbos LD; van den Bergh RC; Roobol MJ; Schröder FH; Essink-Bot ML; Bangma CH; Steyerberg EW; Korfage IJ
Psychooncology; 2015 Mar; 24(3):348-54. PubMed ID: 25138075
[TBL] [Abstract][Full Text] [Related]
2. Do anxiety and distress increase during active surveillance for low risk prostate cancer?
van den Bergh RC; Essink-Bot ML; Roobol MJ; Schröder FH; Bangma CH; Steyerberg EW
J Urol; 2010 May; 183(5):1786-91. PubMed ID: 20299064
[TBL] [Abstract][Full Text] [Related]
3. Anxiety and distress during active surveillance for early prostate cancer.
van den Bergh RC; Essink-Bot ML; Roobol MJ; Wolters T; Schröder FH; Bangma CH; Steyerberg EW
Cancer; 2009 Sep; 115(17):3868-78. PubMed ID: 19637245
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial.
Vasarainen H; Lokman U; Ruutu M; Taari K; Rannikko A
BJU Int; 2012 Jun; 109(11):1614-9. PubMed ID: 22044485
[TBL] [Abstract][Full Text] [Related]
5. A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer.
Punnen S; Cowan JE; Dunn LB; Shumay DM; Carroll PR; Cooperberg MR
BJU Int; 2013 Jul; 112(2):E67-75. PubMed ID: 23795800
[TBL] [Abstract][Full Text] [Related]
6. Investigating the psychological impact of active surveillance or active treatment in newly diagnosed favorable-risk prostate cancer patients: A 9-month longitudinal study.
Ruane-McAteer E; Porter S; O'Sullivan J; Dempster M; Prue G
Psychooncology; 2019 Aug; 28(8):1743-1752. PubMed ID: 31243872
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer.
Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
Urology; 2004 Apr; 63(4):751-6. PubMed ID: 15072894
[TBL] [Abstract][Full Text] [Related]
8. Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance.
Parker PA; Davis JW; Latini DM; Baum G; Wang X; Ward JF; Kuban D; Frank SJ; Lee AK; Logothetis CJ; Kim J
BJU Int; 2016 Mar; 117(3):469-77. PubMed ID: 25714186
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer.
van den Bergh RC; Korfage IJ; Borsboom GJ; Steyerberg EW; Essink-Bot ML
Qual Life Res; 2009 Oct; 18(8):1061-6. PubMed ID: 19669670
[TBL] [Abstract][Full Text] [Related]
10. Anxiety in the management of localised prostate cancer by active surveillance.
Anderson J; Burney S; Brooker JE; Ricciardelli LA; Fletcher JM; Satasivam P; Frydenberg M
BJU Int; 2014 Nov; 114 Suppl 1():55-61. PubMed ID: 25070423
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer.
Tavlarides AM; Ames SC; Diehl NN; Joseph RW; Castle EP; Thiel DD; Broderick GA; Parker AS
Psychooncology; 2013 Jun; 22(6):1328-35. PubMed ID: 22855322
[TBL] [Abstract][Full Text] [Related]
12. Anxiety and health-related quality of life (HRQL) in patients undergoing active surveillance of prostate cancer in an Australian centre.
Wilcox CB; Gilbourd D; Louie-Johnsun M
BJU Int; 2014 Mar; 113 Suppl 2():64-8. PubMed ID: 24894853
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of cancer specific distress in men with a family history of prostate cancer.
McDowell ME; Occhipinti S; Gardiner RA; Chambers SK
Psychooncology; 2013 Nov; 22(11):2496-504. PubMed ID: 23712946
[TBL] [Abstract][Full Text] [Related]
14. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
[TBL] [Abstract][Full Text] [Related]
15. Italian cultural adaptation of the Memorial Anxiety for Prostate Cancer scale for the population of men on active surveillance.
Alvisi MF; Repetto C; Rancati T; Badenchini F; Magnani T; Marenghi C; Villa S; Nicolai N; Salvioni R; Avuzzi B; Valdagni R; Bellardita L;
Tumori; 2018 Jun; 104(3):172-178. PubMed ID: 28623635
[TBL] [Abstract][Full Text] [Related]
16. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer.
Roth AJ; Rosenfeld B; Kornblith AB; Gibson C; Scher HI; Curley-Smart T; Holland JC; Breitbart W
Cancer; 2003 Jun; 97(11):2910-8. PubMed ID: 12767107
[TBL] [Abstract][Full Text] [Related]
17. Cross-cultural differences in men on active surveillance' anxiety: a longitudinal comparison between Italian and Dutch patients from the Prostate cancer Research International Active Surveillance study.
Dordoni P; Remmers S; Valdagni R; Bellardita L; De Luca L; Badenchini F; Marenghi C; Roobol MJ; Venderbos LDF
BMC Urol; 2022 Jul; 22(1):110. PubMed ID: 35850672
[TBL] [Abstract][Full Text] [Related]
18. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
[TBL] [Abstract][Full Text] [Related]
19. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
Goh AC; Kowalkowski MA; Bailey DE; Kazer MW; Knight SJ; Latini DM
BJU Int; 2012 Jul; 110(2 Pt 2):E50-6. PubMed ID: 22145791
[TBL] [Abstract][Full Text] [Related]
20. [Psychological impact of prostate cancer on patients receiving a 6-month androgen deprivation therapy].
de la Taille A; Mardoyan S; Lafaye A
Prog Urol; 2018 Jan; 28(1):32-38. PubMed ID: 29223415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
